HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chikako Nishigori Selected Research

Hypohidrosis

10/2022Cross-sectional study of cholinergic urticaria subtypes and bronchial hyperresponsiveness.
9/2020Acquired idiopathic partial anhidrosis successfully treated with adapalene gel.
1/2018Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management.
8/2017Hypohidrosis and metal allergy: Trigger factors for unilateral lichen planus.
4/2015Combined cholinergic urticaria and cold-induced cholinergic urticaria with acquired idiopathic generalized anhidrosis.
4/2009Two novel mutations in the ED1 gene in Japanese families with X-linked hypohidrotic ectodermal dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chikako Nishigori Research Topics

Disease

32Neoplasms (Cancer)
01/2023 - 08/2004
23Melanoma (Melanoma, Malignant)
01/2022 - 11/2003
12Inflammation (Inflammations)
01/2018 - 01/2007
11Urticaria (Hives)
10/2022 - 08/2005
9Skin Neoplasms (Skin Cancer)
04/2019 - 06/2004
8Psoriasis (Pustulosis Palmaris et Plantaris)
06/2023 - 01/2012
8Carcinogenesis
01/2018 - 06/2004
7Chronic Urticaria
07/2022 - 07/2010
6Hypersensitivity (Allergy)
01/2024 - 08/2005
6Hypohidrosis
10/2022 - 04/2009
6Vitiligo
11/2020 - 10/2004
5Xeroderma Pigmentosum (Kaposi's Disease)
02/2024 - 05/2010
5Neoplasm Metastasis (Metastasis)
06/2022 - 02/2005
4Exanthema (Rash)
06/2023 - 06/2015
4Erythema
01/2022 - 07/2013
4Hemangiosarcoma (Angiosarcoma)
07/2020 - 08/2007
4Contact Dermatitis (Eczema, Contact)
01/2019 - 04/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2024 - 01/2011
3Atopic Dermatitis (Atopic Eczema)
01/2024 - 06/2016
3Mycosis Fungoides
02/2022 - 07/2013
3Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 02/2016
3Anaphylaxis (Anaphylactic Shock)
08/2017 - 09/2012
3Skin Diseases (Skin Disease)
01/2012 - 12/2007
2Dermatitis
01/2024 - 08/2007
2Angioedema
10/2022 - 02/2017
2Acneiform Eruptions
06/2022 - 09/2012
2Neutropenia
02/2022 - 08/2007
2Drug Eruptions (Drug Eruption)
01/2022 - 05/2013
2Autoimmune Diseases (Autoimmune Disease)
09/2021 - 01/2018
2Edema (Dropsy)
01/2021 - 07/2013
2DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2018 - 05/2004
2Linear IgA Bullous Dermatosis
01/2018 - 11/2013
2Herpes Zoster
11/2017 - 09/2012
2Sunburn
10/2012 - 07/2012
2Exercise-Induced Allergies
09/2012 - 12/2008
2Infections
09/2012 - 11/2004

Drug/Important Bio-Agent (IBA)

10Cholinergic Agents (Cholinergics)IBA
10/2022 - 08/2005
7Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
6Interleukin-27 (Interleukin 27)IBA
01/2013 - 06/2006
6DNA (Deoxyribonucleic Acid)IBA
08/2012 - 05/2004
4Pyrimidine DimersIBA
01/2023 - 12/2007
4AntigensIBA
04/2020 - 06/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
02/2017 - 06/2004
48-hydroxyguanineIBA
10/2014 - 06/2004
4ThioredoxinsIBA
07/2013 - 06/2009
4CytokinesIBA
01/2013 - 10/2004
4Protein Kinase CIBA
07/2010 - 11/2003
3Omalizumab (Xolair)FDA Link
07/2022 - 01/2021
3ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2011
3Sunitinib (Sutent)FDA Link
06/2022 - 08/2019
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2016
3Adapalene (Differin)FDA LinkGeneric
09/2020 - 09/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2012
3Immunoglobulin A (IgA)IBA
01/2019 - 11/2013
3Infliximab (Remicade)FDA Link
01/2018 - 01/2011
3Interleukin-23 (Interleukin 23)IBA
05/2017 - 06/2006
3ChemokinesIBA
01/2017 - 01/2012
3Acetylcholine (Acetylcholine Chloride)FDA Link
06/2015 - 08/2005
3EnzymesIBA
10/2014 - 05/2010
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2012 - 12/2008
3Phospholipases (Phospholipase)IBA
05/2011 - 07/2010
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2010 - 04/2006
2Voriconazole (Vfend)FDA LinkGeneric
02/2024 - 01/2018
2MetalsIBA
01/2024 - 08/2017
2InterleukinsIBA
06/2023 - 05/2017
2Interleukin-17 (Interleukin 17)IBA
06/2023 - 01/2012
2Complementary DNA (cDNA)IBA
04/2023 - 08/2004
2Bexarotene (LGD1069)FDA Link
01/2023 - 02/2022
2Monoclonal AntibodiesIBA
10/2022 - 10/2004
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2022 - 01/2008
2AutoantibodiesIBA
09/2021 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2021 - 04/2009
2rhododendrolIBA
11/2020 - 01/2019
2pazopanibFDA Link
07/2020 - 01/2015
2Histamine H1 AntagonistsIBA
01/2020 - 05/2016
2InterferonsIBA
01/2020 - 07/2013
2Melanins (Melanin)IBA
11/2019 - 06/2004
2A-Form DNA (A-DNA)IBA
04/2019 - 11/2018
2Complement System Proteins (Complement)IBA
10/2018 - 07/2002
2NivolumabIBA
01/2018 - 01/2017
2AllergensIBA
08/2017 - 09/2011
2Versicans (Versican)IBA
02/2017 - 12/2011
2Neutralizing AntibodiesIBA
01/2017 - 01/2013
2Dinoprostone (PGE2)FDA Link
11/2014 - 01/2007
2Estrogens (Estrogen)FDA Link
11/2013 - 05/2004
2Phorbol EstersIBA
05/2011 - 10/2009
2Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
10/2010 - 10/2010
2glycolic acid (glycolate)IBA
10/2010 - 10/2010
2Interleukin-12 (IL 12)IBA
09/2010 - 10/2004
2Tyrosine (L-Tyrosine)FDA Link
10/2009 - 01/2008
2Docetaxel (Taxotere)FDA Link
12/2007 - 08/2007
2Transcription Factors (Transcription Factor)IBA
04/2006 - 02/2006
1ChromiumIBA
01/2024
1TinIBA
01/2024

Therapy/Procedure

9Therapeutics
01/2023 - 03/2010
7Immunotherapy
07/2014 - 10/2004
4Aftercare (After-Treatment)
11/2017 - 01/2008
3Drug Therapy (Chemotherapy)
07/2020 - 02/2005
2Transplantation
05/2021 - 09/2012
2Phototherapy (Light Therapy)
11/2020 - 12/2007